Login / Signup

Instrument Referral Criteria for PlusoptiX, SPOT and 2WIN Targeting 2021 AAPOS Guidelines.

Robert W ArnoldDavid SilbertHeather Modjesky
Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)
The 2021 AAPOS exam guidelines foster early specificity before age 4 and sensitivity after age 4. These evidence-based IRC for current SPOT, PlusoptiX, and 2WIN photoscreeners should allow device manufacturers the data necessary to adjust their device IRC to maximize specificity, sensitivity or a medium between the two. This paper provides practical suggestions for better validation. Improved early screening combined with thorough treatment should reduce life-long vision impairment due to amblyopia.
Keyphrases
  • clinical practice
  • primary care
  • electronic health record
  • cancer therapy
  • big data
  • drug delivery
  • combination therapy
  • patient reported outcomes
  • artificial intelligence